Form 4 Filing for Thomas Paul at Axogen, Inc.

This filing details a Form 4 submission by Thomas Paul, a director at Axogen, Inc. The report, dated June 24, 2026, documents the grant of 5,579 Restricted Stock Units (RSUs) with a transaction value of $0. These RSUs are contingent rights to receive one share of Axogen, Inc. common stock. The grant serves as an annual equity award for Paul's service as a Director. The RSUs are valued at $235,000 as of the grant date and are set to vest on June 24, 2027, marking the one-year anniversary of the grant. The filing indicates that Paul directly owns these securities following the transaction. The RSUs represent a future acquisition of the company's common stock.